e-learning
resources
Virtual 2020
Pre-Congress Content
Experimental approaches to pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of IL-11 system in Pulmonay Hypertension
I. Roger (Valencia, Spain), J. Milara (Valencia, Spain), C. Estornut (Valencia, Spain), A. Bayarri (Valencia, Spain), A. Garcia (Valencia, Spain), J. Cortijo (Valencia, Spain)
Source:
Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Session:
Experimental approaches to pulmonary hypertension
Session type:
E-poster session
Number:
1495
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Roger (Valencia, Spain), J. Milara (Valencia, Spain), C. Estornut (Valencia, Spain), A. Bayarri (Valencia, Spain), A. Garcia (Valencia, Spain), J. Cortijo (Valencia, Spain). Role of IL-11 system in Pulmonay Hypertension. 1495
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Effects of Long Term Exogenous Apelin Application in Experimental Pulmonary Hypertension Model Created with Monocrotaline
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
LATE-BREAKING ABSTRACT: Evaluation of Angiopoietin-2 and Thrombomodulin as Biomarkers for Pulmonary Hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Simulating the Beneficial Effects of Aerobic Exercise in Asthma in vitro: a way to Understand the Cellular Effects of Exercise in Asthma – Involvement of STAT6
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Contribution of BMP9 to Pulmonary Arterial Hypertension
Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension
Year: 2017
Late Breaking Abstract - Peripheral T-cells and their cytokine production in Chronic Thromboembolic Pulmonary Hypertension.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021
Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Liquid biopsy for Chronic Thromboembolic Pulmonary Hypertension: Circulating microRNA profile by Next Generation Sequencing
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Blockade of TSLP pathway alters asthma biomarkers
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
Role of CHK1 in Pulmonary Arterial Hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
TGF-ß1-Mediated CTGF Upregulation Through Transactivation of EGFR in Fibrocytes of Chronic Obstructive Asthma
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Miniaturization of the organ care system
®
into rat lungs for the establishment of
ex-vivo
therapy
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Alpha-1-antitrypsin regulates IL-8 release and CXCR2 expression in human neutrophils
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
Pulmonary Hypertension in Childhood
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept